• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于自我认定的黑人和白人种族,大脑扫描结果的反应在成年人中如何不同。

How reactions to a brain scan result differ for adults based on self-identified Black and White race.

机构信息

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Alzheimers Dement. 2024 Mar;20(3):1527-1537. doi: 10.1002/alz.13558. Epub 2023 Nov 29.

DOI:10.1002/alz.13558
PMID:38029367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10984417/
Abstract

INTRODUCTION

How do reactions to a brain scan result differ between Black and White adults? The answer may inform efforts to reduce disparities in Alzheimer's disease (AD) diagnosis and treatment.

METHODS

Self-identified Black (n = 1055) and White (n = 1451) adults were randomized to a vignette of a fictional patient at a memory center who was told a brain scan result. Measures of stigma and diagnosis confidence were compared between-groups.

RESULTS

Black participants reported more stigma than White participants on four of seven domains in reaction to the patient at a memory center visit. Black participants' confidence in an AD diagnosis informed by a brain scan and other assessments was 72.2 points (95% confidence interval [CI] 70.4 to 73.5), which was lower than the respective rating for White participants [78.1 points (95%CI 77.0 to 79.3)].

DISCUSSION

Equitable access to early AD diagnosis will require public outreach and education that address AD stigma associated with a memory center visit.

摘要

简介

黑人和白人成年人对脑部扫描结果的反应有何不同?答案可能为减少阿尔茨海默病(AD)诊断和治疗方面的差异提供信息。

方法

自我认同的黑人(n=1055)和白人(n=1451)成年人被随机分配到一个虚构的记忆中心患者的小插曲,该患者被告知脑部扫描结果。在组间比较了对记忆中心就诊患者的反应的七个领域中的四个领域的污名化和诊断信心的措施。

结果

在记忆中心就诊时,黑人参与者对患者的反应在七个领域中的四个领域的污名化程度高于白人参与者。黑人参与者对脑部扫描和其他评估提示 AD 诊断的信心为 72.2 分(95%置信区间[CI]70.4 至 73.5),低于白人参与者的相应评分[78.1 分(95%CI 77.0 至 79.3)]。

讨论

要实现早期 AD 诊断的公平获取,需要进行公共宣传和教育,以解决与记忆中心就诊相关的 AD 污名化问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/10984417/47951587a45d/ALZ-20-1527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/10984417/388557db3316/ALZ-20-1527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/10984417/327b4cdd9b8d/ALZ-20-1527-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/10984417/47951587a45d/ALZ-20-1527-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/10984417/388557db3316/ALZ-20-1527-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/10984417/327b4cdd9b8d/ALZ-20-1527-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d406/10984417/47951587a45d/ALZ-20-1527-g002.jpg

相似文献

1
How reactions to a brain scan result differ for adults based on self-identified Black and White race.基于自我认定的黑人和白人种族,大脑扫描结果的反应在成年人中如何不同。
Alzheimers Dement. 2024 Mar;20(3):1527-1537. doi: 10.1002/alz.13558. Epub 2023 Nov 29.
2
Double-Edged Sword: A Positive Brain Scan Result Heightens Confidence in an Alzheimer's Diagnosis But Also Leads to Higher Stigma Among Older Adults in a Vignette-Based Experiment.双刃剑:基于情景实验的研究发现,阿尔茨海默病诊断中正面的脑部扫描结果会增强患者信心,但也会导致老年人面临更高的污名化。
J Gerontol B Psychol Sci Soc Sci. 2024 Aug 1;79(8). doi: 10.1093/geronb/gbae109.
3
A survey study of Alzheimer's stigma among Black adults: intersectionality of Black identity and biomarker diagnosis.一项针对黑人成年人阿尔茨海默病污名的调查研究:黑人身份和生物标志物诊断的交叉性。
Ethn Health. 2024 Nov;29(8):946-962. doi: 10.1080/13557858.2024.2385110. Epub 2024 Jul 30.
4
The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment.生物标志物、疾病修正治疗和痴呆严重程度对阿尔茨海默病污名的相对贡献:基于情景的实验。
Soc Sci Med. 2022 Jan;292:114620. doi: 10.1016/j.socscimed.2021.114620. Epub 2021 Dec 1.
5
The Community Engaged Digital Alzheimer's Research (CEDAR) Study: A Digital Intervention to Increase Research Participation of Black American Participants in the Brain Health Registry.社区参与式数字阿尔茨海默病研究(CEDAR):一项数字干预措施,旨在增加美国黑人参与者在大脑健康注册中心的研究参与度。
J Prev Alzheimers Dis. 2023;10(4):847-856. doi: 10.14283/jpad.2023.32.
6
Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.成年人参与临床前阿尔茨海默病试验的种族和民族差异。
JAMA Netw Open. 2021 Jul 1;4(7):e2114364. doi: 10.1001/jamanetworkopen.2021.14364.
7
Brain MRI findings related to Alzheimer's disease in older African American adults.老年非裔美国人阿尔茨海默病相关的脑 MRI 表现。
Prog Mol Biol Transl Sci. 2019;165:3-23. doi: 10.1016/bs.pmbts.2019.04.002. Epub 2019 May 15.
8
Quantification of race/ethnicity representation in Alzheimer's disease neuroimaging research in the USA: a systematic review.美国阿尔茨海默病神经影像学研究中种族/族裔代表性的量化:一项系统综述。
Commun Med (Lond). 2023 Jul 25;3(1):101. doi: 10.1038/s43856-023-00333-6.
9
Understanding Barriers and Facilitators to Signing Up for a Mobile-Responsive Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.了解健康志愿者和代表性不足社区成员报名参加移动响应注册以参与阿尔茨海默病预防研究的障碍和促进因素。
J Prev Alzheimers Dis. 2023;10(4):865-874. doi: 10.14283/jpad.2023.67.
10
Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis.非裔美国人或非洲黑人与白人之间阿尔茨海默病的体液生物标志物比较:一项系统评价和荟萃分析。
J Neurol Sci. 2021 Feb 15;421:117270. doi: 10.1016/j.jns.2020.117270. Epub 2020 Dec 15.

引用本文的文献

1
Are Knowledge and Interpersonal Contact Cures for Alzheimer's Stigma? Data From Caregivers Offer Clues.知识和人际接触能消除对阿尔茨海默病的污名化吗?来自护理人员的数据提供了线索。
Stigma Health. 2025 May;10(2):199-213. doi: 10.1037/sah0000601. Epub 2025 Jan 13.
2
Older US adults' experiences with and views about cognitive screening and blood biomarker testing for Alzheimer's disease.美国老年人对阿尔茨海默病认知筛查和血液生物标志物检测的经历及看法。
Alzheimers Dement (Amst). 2025 Jan 16;17(1):e70067. doi: 10.1002/dad2.70067. eCollection 2025 Jan-Mar.
3
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial.

本文引用的文献

1
Let's Not Repeat History's Mistakes: Two Cautions to Scientists on the Use of Race in Alzheimer's Disease and Alzheimer's Disease Related Dementias Research.避免重蹈历史覆辙:关于在阿尔茨海默病和阿尔茨海默病相关痴呆症研究中使用种族问题,给科学家的两点警示。
J Alzheimers Dis. 2023;92(3):729-740. doi: 10.3233/JAD-220507.
2
The Return of Race Science and Why It Matters for Family Science.种族科学的回归及其对家庭科学的重要性
J Fam Theory Rev. 2022 Sep;14(3):442-462. doi: 10.1111/jftr.12472. Epub 2022 Aug 9.
3
Experiences of Black American Dementia Caregivers During the COVID-19 Pandemic.
在一项临床前阿尔茨海默病试验中对淀粉样蛋白成像的观点和看法。
J Prev Alzheimers Dis. 2024;11(6):1563-1571. doi: 10.14283/jpad.2024.157.
4
A survey study of Alzheimer's stigma among Black adults: intersectionality of Black identity and biomarker diagnosis.一项针对黑人成年人阿尔茨海默病污名的调查研究:黑人身份和生物标志物诊断的交叉性。
Ethn Health. 2024 Nov;29(8):946-962. doi: 10.1080/13557858.2024.2385110. Epub 2024 Jul 30.
5
Double-Edged Sword: A Positive Brain Scan Result Heightens Confidence in an Alzheimer's Diagnosis But Also Leads to Higher Stigma Among Older Adults in a Vignette-Based Experiment.双刃剑:基于情景实验的研究发现,阿尔茨海默病诊断中正面的脑部扫描结果会增强患者信心,但也会导致老年人面临更高的污名化。
J Gerontol B Psychol Sci Soc Sci. 2024 Aug 1;79(8). doi: 10.1093/geronb/gbae109.
6
Alzheimer disease blood biomarkers: considerations for population-level use.阿尔茨海默病血液生物标志物:在人群水平应用的考虑因素。
Nat Rev Neurol. 2024 Aug;20(8):495-504. doi: 10.1038/s41582-024-00989-1. Epub 2024 Jun 11.
美国黑人在 COVID-19 大流行期间照顾痴呆症患者的经历。
J Fam Nurs. 2022 Aug;28(3):195-204. doi: 10.1177/10748407221102465. Epub 2022 Jun 8.
4
The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment.生物标志物、疾病修正治疗和痴呆严重程度对阿尔茨海默病污名的相对贡献:基于情景的实验。
Soc Sci Med. 2022 Jan;292:114620. doi: 10.1016/j.socscimed.2021.114620. Epub 2021 Dec 1.
5
Alzheimer disease in African American individuals: increased incidence or not enough data?非裔美国人的阿尔茨海默病:发病率增加还是数据不足?
Nat Rev Neurol. 2022 Jan;18(1):56-62. doi: 10.1038/s41582-021-00589-3. Epub 2021 Dec 6.
6
Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.黑人和白人在痴呆症的患病率、风险因素和症状表现方面存在差异。
Alzheimers Dement. 2022 Aug;18(8):1461-1471. doi: 10.1002/alz.12509. Epub 2021 Dec 2.
7
Alzheimer disease.阿尔茨海默病。
Nat Rev Dis Primers. 2021 May 13;7(1):33. doi: 10.1038/s41572-021-00269-y.
8
Racial disparities and temporal trends in dementia misdiagnosis risk in the United States.美国痴呆症误诊风险中的种族差异与时间趋势
Alzheimers Dement (N Y). 2019 Dec 9;5:891-898. doi: 10.1016/j.trci.2019.11.008. eCollection 2019.
9
Biomarkers for Alzheimer's disease: current status and prospects for the future.阿尔茨海默病的生物标志物:现状与未来展望。
J Intern Med. 2018 Dec;284(6):643-663. doi: 10.1111/joim.12816. Epub 2018 Aug 19.
10
Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease.阿尔茨海默病成像技术的进展正在改变阿尔茨海默病的诊疗体验。
Alzheimers Dement (Amst). 2018 Mar 19;10:285-300. doi: 10.1016/j.dadm.2018.02.006. eCollection 2018.